PCOS患者IVM与标准促排卵后IVF/ICSI的早期妊娠丢失比较
本回顾性队列研究纳入800例符合鹿特丹标准的PCOS不孕患者,比较未成熟卵母细胞体外成熟(IVM)与常规卵巢刺激(OS)后首次妊娠阳性者的早期妊娠丢失(EPL)。新鲜胚胎移植后IVM组EPL显著高于OS组,而冻融胚胎移植后两组无显著差异。
要点
- PCOS患者新鲜胚胎移植后,IVM组EPL风险显著高于OS组。
- 冻融胚胎移植后IVM与OS的EPL发生率无显著差异。
- IVM后采用全胚冷冻策略可能更合适。
核心结论
- PCOS患者新鲜胚胎移植后IVM的EPL概率高于OS,但冻融胚胎移植后两者EPL发生率无显著差异。
研究设计与样本
- 回顾性队列研究,纳入2010年1月至2017年12月单中心800例符合鹿特丹标准的PCOS不孕患者。
- 比较短程高纯度人绝经期促性腺激素后非hCG触发IVM与常规OS后的妊娠结局。
- 主要结局EPL定义为妊娠10周前的自发性妊娠丢失。
主要发现
- IVM组329例妊娠阳性,OS组471例妊娠阳性。
- IVM组年龄更小(28.6±3.4岁 vs 29.3±3.6岁,P=0.005),抗苗勒管激素更高(11.5±8.1 ng/ml vs 7.2±4.1 ng/ml,P<0.001)。
- OS组既往EPL史更常见(28% vs 17.6%,P=0.003)。
- 新鲜胚胎移植后EPL:IVM组57/122(46.7%)vs OS组53/305(17.4%),P<0.001。
- 冻融胚胎移植后EPL:IVM组63/207(30.4%)vs OS组60/166(36.1%),P=0.24。
关键数值与推荐
- 新鲜胚胎移植周期多因素logistic回归中,IVM是唯一独立因素(aOR 4.24,95%CI 2.44-7.37,P<0.001)。
- 冻融胚胎移植周期同样模型中,治疗类型与EPL无显著关联(aOR 0.73,95%CI 0.43-1.25,P=0.25)。
临床怎么用
- PCOS患者行IVM后新鲜胚胎移植需警惕EPL风险升高。
- IVM后采用全胚冷冻策略可能更为合适。
局限性
- 回顾性研究设计。
- 可能存在未测量混杂因素导致的偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the incidence of early pregnancy loss (EPL) in patients with polycystic ovary syndrome (PCOS) higher after IVM of oocytes than after ovarian stimulation (OS) for IVF/ICSI? SUMMARY ANSWER: Women with PCOS who are pregnant after fresh embryo transfer have a higher probability of EPL following IVM, but after frozen embryo transfer (FET), no significant difference in the incidence of EPL was observed following IVM compared to OS. WHAT IS KNOWN ALREADY: There is conflicting evidence in the current literature with regard to the risk of EPL after IVM of oocytes when compared with OS. Because of the limited sample size in previous studies, the use of different IVM systems and the possible bias introduced by patient characteristics and treatment type, firm conclusions cannot be drawn. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study evaluating 800 women, with a diagnosis of infertility and PCOS as defined by Rotterdam criteria, who had a first positive pregnancy test after fresh or FET following IVM or OS between January 2010 and December 2017 in a tertiary care academic medical centre. PARTICIPANTS/MATERIALS, SETTING, METHODS: Pregnancies after non-hCG triggered IVM following a short course of highly purified human menopausal gonadotropin were compared with those after conventional OS. The primary outcome was EPL, defined as a spontaneous pregnancy loss before 10 weeks of gestation. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 329 patients with a positive pregnancy test after IVM and 471 patients with a positive pregnancy test after OS were included. Women who were pregnant after IVM were younger (28.6 ± 3.4 years vs 29.3 ± 3.6 years, P = 0.005) and had higher serum anti-Mullerian hormone levels (11.5 ± 8.1 ng/ml vs 7.2 ± 4.1 ng/ml, P < 0.001) compared to those who were pregnant after OS. The distribution of PCOS phenotypes was significantly different among women in the IVM group compared to those in the OS group and women who were pregnant after OS had previously suffered EPL more often (28% vs 17.6%, P = 0.003). EPL was significantly higher after fresh embryo transfer following IVM compared to OS (57/122 (46.7%) vs 53/305 (17.4%), P < 0.001), while the results were comparable after FET (63/207 (30.4%) vs 60/166 (36.1%), respectively, P = 0.24). In the multivariate logistic regression analysis evaluating fresh embryo transfer cycles, IVM was the only independent factor (adjusted odds ratio (aOR) 4.24, 95% CI 2.44-7.37, P < 0.001)) significantly associated with increased odds of EPL. On the other hand, when the same model was applied to FET cycles, the type of treatment (IVM vs OS) was not significantly associated with EPL (aOR 0.73, 95% CI 0.43-1.25, P = 0.25). LIMITATIONS, REASONS FOR CAUTION: The current data are limited by the retrospective nature of the study and the potential of bias due to unmeasured confounders. WIDER IMPLICATIONS OF THE FINDINGS: The increased risk of EPL after fresh embryo transfer following IVM may point towards inadequate endometrial development in IVM cycles. Adopting a freeze-all strategy after IVM seems more appropriate. Future studies are needed to ascertain the underlying cause of this observation. STUDY FUNDING/COMPETING INTEREST(S): The Clinical IVM research has been supported by research grants from Cook Medical and Besins Healthcare. All authors declared no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Mackens S, Mostinckx L, Drakopoulos P, et al. Early pregnancy loss in patients with polycystic ovary syndrome after IVM versus standard ovarian stimulation for IVF/ICSI. Hum Reprod. 2020. PMID: 33025015. doi:10.1093/humrep/deaa200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。